Invokana Lawsuit

Invokana lawsuits are currently being filed against the manufacturer of Invokana, Johnson & Johnson, on behalf of individuals who believe they were injured as a result of using the popular type II diabetes drug, Invokana.  Type II diabetes drugs including Invokana, Jardiance, Farxiga, and Invokamet are linked to serious injuries including Diabetic Ketoacidosis, Kidney Failure, Bladder Cancer and others.

FDA WARNS – Invokana, Farxiga and Jardiance Linked to Diabetic Ketoacidosis and Kidney Failure

On May 15, 2015 FDA issued a safety warning that the type-2 diabetes mellitus (DM) drugs canagliflozin (Invokana, Johnson & Johnson), dapagliflozin (Farxiga, AstraZeneca plc) and empagliflozin (Jardiance, Boehringer Ingelheim GmbH and Eli Lilly & Company) belonging to SGLT-2 class inhibitors may cause diabetic ketoacidosis, a serious condition that makes blood acidic due to the presence of ketones.

Invokana FDA Alert

FDA Warning Logo According to the FDA safety alert, patients should stop taking their SGLT2 inhibitor and seek medical attention immediately if they have any symptoms of ketoacidosis, a serious condition in which the body produces high levels of blood acids called ketones.

SGLT-2 inhibitors (including Invokana, Farxiga and Jardiance) are a class of FDA approved drugs prescribed for type-2 diabetes patients in conjunction with diet and exercise to lower blood glucose levels. These drugs block glucose reabsorption from the kidney, thus increasing urinary glucose excretion and reducing blood glucose levels.

Diabetic Ketoacidosis

Diabetic Ketoacidosis is an acute metabolic complication of diabetes, also referred to as diabetic ketoacidosis (DKA). DKA occurs when insulin levels are inadequate to meet the body’s basic metabolic requirements. Insulin deficiency leads to the formation of free fatty acids due to the breakdown of triglycerides and amino acids, which get converted to highly acidic ketone bodies, leading to acidosis. Symptoms include nausea, vomiting, and abdominal pain that can progress to kidney failure, cerebral edema, coma, and death.

Injured by Invokana or Another Type II Diabetes Drug?
Get Instant Online Analysis Now!

Symptoms of Diabetic Ketoacidosis

Nausea Vomiting
Abdominal Pain Tiredness
Trouble Breathing Rapid Weight Loss
Excessive Thirst Lower stomach or pelvic pain
Sweet smell to the breath and/or a sweet metallic taste in the mouth Signs and symptoms of a urinary tract infection, which includes a feeling of burning when urinating or the need to urinate often or right away
Error: Untreated symptoms of ketoacidosis can lead to kidney failure, cerebral edema, coma or death.

Regulatory Timeline

  • 2013
  • FDA Approves Invokana

    Mar 29, 2013

  • 2014
  • Initial FDA Alert

    May 01, 2014

    FDA Warns of Acute Kidney Injury and Impairment in Renal Function

  • Mar 2013 - Oct 2014
  • Life-Threatening Blood Infections

    The FDA identified 19 cases of life-threatening blood infections (urosepsis) and kidney infections (pyelonephritis) that started as urinary tract infections with the SGLT2 inhibitors reported to FAERS from March 2013 through October 2014. All 19 patients identified were hospitalized, and a few required admission to an intensive care unit or dialysis in order to treat kidney failure.

  • Mar 2013 - May 2015
  • 73 Cases of Ketoacidosis

    According to an FDA review of the FDA Adverse Event Reporting System (FAERS) database from March 2013 to May 2015, 73 cases of ketoacidosis in patients with type 1 or type 2 diabetes treated with SGLT2 inhibitors.

  • Feb 2016
  • Recommendations to Minimize the Risk of Diabetic Ketoacidosis

    In February 2016, the European Medicines Agency (EMA) confirmed recommendations to minimize the risk of diabetic ketoacidosis in patients taking SGLT2 inhibitors including Invokana, Farxiga and Jardiance. According to the EMA notice, patients taking these medicines need to be aware of the symptoms of diabetic ketoacidosis (DKA) According to Advera Health’s RX Signal, the number of individuals experiencing diabetic ketoacidosis noted by the FDA is understated. According to Advera health, there were 71 cases of DKA from Invokana use and 28 cases of DKA with Farxiga use. These reported numbers are likely to increase as more individuals become aware of the link between SLGT-2 inhibitors and ketoacidosis.

Invokana Frequently Asked Questions

Sometimes you need a lawyer near you and sometimes its best to hire a lawyer based on the lawyer’s resources and experiences.

The right lawyer for mass-tort litigations may not be your local lawyer. Mass tort cases filed all over the country are often consolidated into a single courtroom in order to move the many lawsuits through the courts in the most effective and efficient way. A lawyer experienced with the multidistrict litigation process with the ability to represent clients in all 50 states, is likely to be a good fit for mass tort litigation.

TruLaw is not afraid to take on the largest drug and medical device companies in the world. We work with trusted legal affiliates to make sure that TruLaw clients have the resources and experiences needed to hold big business accountable when they put profits over people.

Your Invokana, Invokamet, Jardiance, or Farxiga lawsuit is designed to help you financially recover from injuries that were caused by someone else. We hope putting your trust in TruLaw will take away your concern of protecting your legal rights., but it is most important to us that you spend your time recovering physically.

Your lawsuit should assist in covering your medical bills, the amount of income and benefits that you lost as a result of your injury and, if your injuries are permanent, we will look to recover for your permanent disfigurement.

In addition, it is always our hope that your lawsuit will help us to remove dangerous drugs, toxins and devices from the market. We are not only lawyers, but also safety advocates that believe in getting information out to the public so no more people are injured. We hope you will join us in the role as a safety advocate.

We understand the frustration in waiting to hear about settlements in product liability lawsuits. Unfortunately, in drug and device cases, we have no choice but to sue some of the most profitable companies in the world. Big Pharma has deep pockets and lawsuits are a cost of doing business for them. They are not inclined to settle until it makes business sense to them.

TruLaw lawyers building our cases with an eye on winning in court as well as settlement, when we believe that is the best result for our clients. We will never settle without advising you of your options, and we will keep you posted on our progress, to the extent we are legally able.

We often hear injured people refer to their personal injury case as a “class action” because their case was grouped together in a lawsuit with other injured people. This is most often NOT the case. Often, individual cases are grouped together so the attorneys and judge can address common procedural issues initially, saving time for the injured parties and the court, but this is very generally referred to as a “mass tort.”

A Mass tort refers to civil actions involving numerous plaintiffs against one or a few corporate defendants in state or federal court. Class actions are mass torts that are generally used on financial losses and multidistrict litigations (MDL) are generally used on personal injury claims, often in product liability cases.

MDL is a procedural tool used when plaintiffs have incurred injuries from products manufactured by the same defendant(s). Even when plaintiffs incur injuries from the same defendant(s), the amount of damages they may recover for those injuries are often substantially different from other plaintiffs included in the same lawsuit.

It is important to understand that mass tort cases are an effective tool to getting the attention of the large drug and device companies. MDLs assist lawyers in determining exactly what the drug and device companies knew about the risks their products caused and whether or not they should have warned consumers. Too often, consumers believe that they can file a single lawsuit and get the attention of big drug companies. This is very hard to do.

Technically, MDLs do not happen until a judicial panel transfers individual cases to a single court. Depending on when your lawsuit is filed, you may find yourself automatically transferred to the MDL court or you may wait to learn when and if the JPML believes an MDL is the proper venue for the mass tort.

But, rest assured, even if your case is included in an MDL, TruLaw lawyers will treat your injuries, your medical history and your financial needs separately. We are aware that not all cases are the same.

A corporation, by definition is profit seeking. There is no requirement that a corporation act morally. Unfortunately, too often we see dangerous drugs, devices and products remain on the market when corporations prioritize profit over people.

If these same corporations warn consumers of these risks, there is no case. We only pursue lawsuits on behalf of individuals who were not warned of the risk associated with the dangerous drug, device or product on the market.

TruLaw is pursuing Invokana, Invokamet, Jardiance, and Farxiga lawsuits because we believe consumers were not properly warned of the risks of injury.

Did a recent Invokana or diabetes drug commercial grab your attention? Did you find our site because you were wondering if you qualify for Invokana lawsuits?

We built the Invokana Instant Case Evaluator ℠ as a no cost/no obligation place for you to find answers about your legal rights. If you found us today, you are looking for instant answers to whether you should file a Invokana, Invokamet, Jardiance, or Farxiga lawsuit and we want to help you. We believe that in order for you to make important decisions about your health and your legal rights, you need to start with information. We provide you this valuable information so you are prepared to talk to a lawyer.